nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—ADRB2—polycystic ovary syndrome	0.8	1	CbGaD
Ritodrine—GALR3—uterus—polycystic ovary syndrome	0.00789	0.319	CbGeAlD
Ritodrine—PGD—adrenal cortex—polycystic ovary syndrome	0.0024	0.097	CbGeAlD
Ritodrine—PGD—endometrium—polycystic ovary syndrome	0.00214	0.0866	CbGeAlD
Ritodrine—PGD—uterus—polycystic ovary syndrome	0.00197	0.0798	CbGeAlD
Ritodrine—PGD—pituitary gland—polycystic ovary syndrome	0.00194	0.0784	CbGeAlD
Ritodrine—PGD—adipose tissue—polycystic ovary syndrome	0.00193	0.0781	CbGeAlD
Ritodrine—Fenoterol—ADRB3—polycystic ovary syndrome	0.00185	0.18	CrCbGaD
Ritodrine—PGD—adrenal gland—polycystic ovary syndrome	0.00173	0.07	CbGeAlD
Ritodrine—Arbutamine—ADRB3—polycystic ovary syndrome	0.00173	0.168	CrCbGaD
Ritodrine—PGD—female gonad—polycystic ovary syndrome	0.00161	0.0653	CbGeAlD
Ritodrine—PGD—vagina—polycystic ovary syndrome	0.0016	0.0649	CbGeAlD
Ritodrine—PGD—endocrine gland—polycystic ovary syndrome	0.0015	0.0607	CbGeAlD
Ritodrine—Labetalol—ADRB3—polycystic ovary syndrome	0.00123	0.119	CrCbGaD
Ritodrine—Diethylstilbestrol—CYP19A1—polycystic ovary syndrome	0.000743	0.0724	CrCbGaD
Ritodrine—Fenoterol—ADRB2—polycystic ovary syndrome	0.000702	0.0685	CrCbGaD
Ritodrine—Arbutamine—ADRB2—polycystic ovary syndrome	0.000657	0.064	CrCbGaD
Ritodrine—Arformoterol—ADRB2—polycystic ovary syndrome	0.000638	0.0622	CrCbGaD
Ritodrine—Formoterol—ADRB2—polycystic ovary syndrome	0.000638	0.0622	CrCbGaD
Ritodrine—Dobutamine—ADRB2—polycystic ovary syndrome	0.000605	0.0589	CrCbGaD
Ritodrine—Bezafibrate—PPARG—polycystic ovary syndrome	0.000602	0.0587	CrCbGaD
Ritodrine—Labetalol—ADRB2—polycystic ovary syndrome	0.000466	0.0454	CrCbGaD
Ritodrine—GALR3—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000412	0.0025	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.000409	0.00248	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.000409	0.00248	CbGpPWpGaD
Ritodrine—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.000409	0.00248	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000408	0.00247	CbGpPWpGaD
Ritodrine—Bezafibrate—CYP1A1—polycystic ovary syndrome	0.000407	0.0397	CrCbGaD
Ritodrine—GALR3—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000403	0.00244	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000395	0.0024	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000388	0.00235	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000385	0.00234	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000383	0.00232	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.000383	0.00232	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000378	0.00229	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000377	0.00229	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000375	0.00227	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.000372	0.00225	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.000361	0.00219	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000359	0.00218	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000356	0.00216	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000356	0.00216	CbGpPWpGaD
Ritodrine—PGD—Metabolism—AKR1C2—polycystic ovary syndrome	0.000353	0.00214	CbGpPWpGaD
Ritodrine—PGD—Metabolism—TEAD2—polycystic ovary syndrome	0.000353	0.00214	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.000351	0.00213	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.000351	0.00213	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 trafficking events—INS—polycystic ovary syndrome	0.000345	0.00209	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000343	0.00208	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000335	0.00203	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000333	0.00202	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.000328	0.00199	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000323	0.00196	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00032	0.00194	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.000318	0.00193	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000314	0.0019	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00031	0.00188	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000306	0.00186	CbGpPWpGaD
Ritodrine—PGD—Disease—RPL37A—polycystic ovary syndrome	0.0003	0.00182	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.0003	0.00182	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PNPLA2—polycystic ovary syndrome	0.000296	0.00179	CbGpPWpGaD
Ritodrine—ADRB2—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000295	0.00179	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000286	0.00173	CbGpPWpGaD
Ritodrine—PGD—Disease—HMMR—polycystic ovary syndrome	0.000285	0.00173	CbGpPWpGaD
Ritodrine—PGD—Metabolism—SRD5A1—polycystic ovary syndrome	0.000281	0.0017	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000279	0.00169	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000274	0.00166	CbGpPWpGaD
Ritodrine—PGD—Metabolism—STAR—polycystic ovary syndrome	0.000268	0.00162	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000267	0.00162	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000267	0.00162	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000264	0.0016	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00026	0.00158	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000257	0.00156	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000255	0.00154	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000253	0.00153	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00025	0.00151	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000245	0.00148	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000242	0.00147	CbGpPWpGaD
Ritodrine—PGD—Metabolism—HMMR—polycystic ovary syndrome	0.000239	0.00145	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000238	0.00144	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000237	0.00144	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000236	0.00143	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000235	0.00142	CbGpPWpGaD
Ritodrine—PGD—Disease—AKR1C1—polycystic ovary syndrome	0.000235	0.00142	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000233	0.00141	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FST—polycystic ovary syndrome	0.000232	0.00141	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000231	0.0014	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000229	0.00139	CbGpPWpGaD
Ritodrine—PGD—Metabolism—HSD3B1—polycystic ovary syndrome	0.000228	0.00138	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000226	0.00137	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000226	0.00137	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000223	0.00135	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000221	0.00134	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000218	0.00132	CbGpPWpGaD
Ritodrine—PGD—Disease—FGF18—polycystic ovary syndrome	0.000218	0.00132	CbGpPWpGaD
Ritodrine—PGD—Disease—RBP4—polycystic ovary syndrome	0.000216	0.00131	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000214	0.0013	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000214	0.0013	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000212	0.00129	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000209	0.00127	CbGpPWpGaD
Ritodrine—PGD—Metabolism—LHB—polycystic ovary syndrome	0.000208	0.00126	CbGpPWpGaD
Ritodrine—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000205	0.00124	CbGpPWpGaD
Ritodrine—PGD—Metabolism—HSD3B2—polycystic ovary syndrome	0.000203	0.00123	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000202	0.00123	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.0002	0.00121	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000199	0.00121	CbGpPWpGaD
Ritodrine—PGD—Disease—GAB1—polycystic ovary syndrome	0.000199	0.0012	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000197	0.0012	CbGpPWpGaD
Ritodrine—PGD—Metabolism—AKR1C1—polycystic ovary syndrome	0.000196	0.00119	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000195	0.00118	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000194	0.00118	CbGpPWpGaD
Ritodrine—PGD—Disease—NAMPT—polycystic ovary syndrome	0.000194	0.00117	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000184	0.00112	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000182	0.0011	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000181	0.0011	CbGpPWpGaD
Ritodrine—PGD—Metabolism—SULT2A1—polycystic ovary syndrome	0.000181	0.0011	CbGpPWpGaD
Ritodrine—PGD—Disease—AKR1C3—polycystic ovary syndrome	0.000181	0.00109	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000179	0.00108	CbGpPWpGaD
Ritodrine—PGD—Disease—TNRC6B—polycystic ovary syndrome	0.000178	0.00108	CbGpPWpGaD
Ritodrine—PGD—Metabolism—RRM2—polycystic ovary syndrome	0.000175	0.00106	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000174	0.00105	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000172	0.00104	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00017	0.00103	CbGpPWpGaD
Ritodrine—PGD—Metabolism—YAP1—polycystic ovary syndrome	0.000169	0.00102	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000166	0.00101	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000165	0.001	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000164	0.000995	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000163	0.000991	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000162	0.000985	CbGpPWpGaD
Ritodrine—PGD—Metabolism—NAMPT—polycystic ovary syndrome	0.000162	0.000983	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000161	0.000975	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CYP11A1—polycystic ovary syndrome	0.00016	0.000971	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00016	0.00097	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00016	0.00097	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.00016	0.000969	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000159	0.000966	CbGpPWpGaD
Ritodrine—PGD—Disease—TCF7L2—polycystic ovary syndrome	0.000152	0.000923	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000152	0.000921	CbGpPWpGaD
Ritodrine—PGD—Metabolism—AKR1C3—polycystic ovary syndrome	0.000151	0.000917	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000151	0.000915	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000151	0.000915	CbGpPWpGaD
Ritodrine—PGD—Disease—SLC2A4—polycystic ovary syndrome	0.00015	0.000907	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000149	0.000906	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000149	0.000906	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CYP17A1—polycystic ovary syndrome	0.000149	0.000902	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000148	0.0009	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000147	0.000893	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000144	0.000873	CbGpPWpGaD
Ritodrine—PGD—Disease—PRL—polycystic ovary syndrome	0.000143	0.000865	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000143	0.000864	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000141	0.000856	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000139	0.000843	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000138	0.000839	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000137	0.000831	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000137	0.000831	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000137	0.000831	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000133	0.000808	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000132	0.000798	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000131	0.000793	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PRL—polycystic ovary syndrome	0.00013	0.000791	CbGpPWpGaD
Ritodrine—PGD—Metabolism—TH—polycystic ovary syndrome	0.000129	0.000781	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000128	0.000777	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000126	0.000762	CbGpPWpGaD
Ritodrine—PGD—Metabolism—SLC2A4—polycystic ovary syndrome	0.000125	0.00076	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000124	0.000754	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000124	0.00075	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000121	0.000735	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000121	0.000734	CbGpPWpGaD
Ritodrine—PGD—Disease—NCOR1—polycystic ovary syndrome	0.00012	0.000725	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CYP19A1—polycystic ovary syndrome	0.000118	0.000714	CbGpPWpGaD
Ritodrine—PGD—Disease—NRG1—polycystic ovary syndrome	0.000117	0.000712	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000115	0.000695	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000112	0.00068	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000111	0.000673	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00011	0.000669	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00011	0.000667	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000109	0.000663	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000107	0.00065	CbGpPWpGaD
Ritodrine—PGD—Disease—MTHFR—polycystic ovary syndrome	0.000106	0.000641	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GNAS—polycystic ovary syndrome	0.000105	0.000637	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000101	0.000612	CbGpPWpGaD
Ritodrine—PGD—Disease—IRS2—polycystic ovary syndrome	0.000101	0.00061	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.0001	0.000608	CbGpPWpGaD
Ritodrine—PGD—Metabolism—NCOR1—polycystic ovary syndrome	0.0001	0.000607	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	9.72e-05	0.000589	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	9.7e-05	0.000588	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	9.61e-05	0.000582	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CYP1A1—polycystic ovary syndrome	9.5e-05	0.000576	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	9.39e-05	0.000569	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IRS2—polycystic ovary syndrome	9.19e-05	0.000557	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	9.17e-05	0.000556	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	9e-05	0.000546	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—LEP—polycystic ovary syndrome	8.99e-05	0.000545	CbGpPWpGaD
Ritodrine—PGD—Metabolism—MTHFR—polycystic ovary syndrome	8.85e-05	0.000537	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	8.83e-05	0.000535	CbGpPWpGaD
Ritodrine—PGD—Disease—IRS1—polycystic ovary syndrome	8.78e-05	0.000532	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.77e-05	0.000532	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	8.72e-05	0.000529	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.61e-05	0.000522	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.59e-05	0.000521	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	8.53e-05	0.000517	CbGpPWpGaD
Ritodrine—PGD—Disease—INS—polycystic ovary syndrome	8.41e-05	0.00051	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	8.17e-05	0.000496	CbGpPWpGaD
Ritodrine—PGD—Disease—AKT2—polycystic ovary syndrome	8.13e-05	0.000493	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.09e-05	0.000491	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.09e-05	0.000491	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IRS1—polycystic ovary syndrome	8.02e-05	0.000486	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.8e-05	0.000473	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—POMC—polycystic ovary syndrome	7.72e-05	0.000468	CbGpPWpGaD
Ritodrine—PGD—Disease—SERPINE1—polycystic ovary syndrome	7.72e-05	0.000468	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—INS—polycystic ovary syndrome	7.68e-05	0.000466	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.62e-05	0.000462	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.57e-05	0.000459	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IGF1—polycystic ovary syndrome	7.43e-05	0.00045	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AKT2—polycystic ovary syndrome	7.42e-05	0.00045	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.35e-05	0.000446	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PPARG—polycystic ovary syndrome	7.18e-05	0.000435	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.15e-05	0.000433	CbGpPWpGaD
Ritodrine—PGD—Metabolism—POMC—polycystic ovary syndrome	7.08e-05	0.000429	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.06e-05	0.000428	CbGpPWpGaD
Ritodrine—PGD—Metabolism—INS—polycystic ovary syndrome	7.04e-05	0.000427	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	6.97e-05	0.000422	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.5e-05	0.000394	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.34e-05	0.000385	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	5.92e-05	0.000359	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	5.8e-05	0.000352	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.76e-05	0.000349	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—IL6—polycystic ovary syndrome	5.68e-05	0.000344	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.57e-05	0.000338	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.42e-05	0.000328	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	5.28e-05	0.00032	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.22e-05	0.000316	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	5.15e-05	0.000312	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.04e-05	0.000305	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.88e-05	0.000296	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.87e-05	0.000295	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.85e-05	0.000294	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	4.83e-05	0.000293	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.61e-05	0.000279	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.53e-05	0.000274	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.49e-05	0.000272	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.42e-05	0.000268	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	4.19e-05	0.000254	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	4.13e-05	0.000251	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	3.95e-05	0.00024	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.76e-05	0.000228	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.7e-05	0.000224	CbGpPWpGaD
Ritodrine—PGD—Disease—IL6—polycystic ovary syndrome	3.67e-05	0.000223	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	3.66e-05	0.000222	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.4e-05	0.000206	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.4e-05	0.000206	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL6—polycystic ovary syndrome	3.36e-05	0.000203	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.28e-05	0.000199	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.25e-05	0.000197	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.17e-05	0.000192	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.15e-05	0.000191	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	3e-05	0.000182	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.98e-05	0.00018	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	2.97e-05	0.00018	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.86e-05	0.000173	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.61e-05	0.000158	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.49e-05	0.000151	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.44e-05	0.000148	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.09e-05	0.000127	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	2.05e-05	0.000124	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.83e-05	0.000111	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.76e-05	0.000107	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.75e-05	0.000106	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.69e-05	0.000103	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.69e-05	0.000102	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.61e-05	9.74e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.29e-05	7.84e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.1e-05	6.7e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	7.64e-06	4.63e-05	CbGpPWpGaD
